The terminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal haemoglobinuria

被引：0
|
作者：
Hillmen, P.
Hill, A.
Muus, P.
Duhrsen, U.
Risitano, A. M.
Schubert, J.
Young, N. S.
Schrezenmeier, H.
Szer, J.
Brodsky, R. A.
Socie, G.
Rollins, S. A.
Rother, R. P.
Bell, L.
Luzzatto, L.
机构：
[1] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England
[2] Radboud Univ Med Ctr, Nijmegen, Netherlands
[3] Univ Hosp, Essen, Germany
[4] Med Federico Univ 2, Naples, Italy
[5] Univ Saarland, Sch Med, D-6650 Homburg, Germany
[6] NHLBI, NIH, Bethesda, MD 20892 USA
[7] Inst Klin Transfus & Immunogenet, Helmholtzstr, Germany
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[10] Hosp St Louis, INSERM, Paris, France
[11] Alex Pahrmaceut Inc, Cheshire, CT USA
[12] Ist Toscano Tumori, Florence, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
102
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [41] Not Happily Ever After: Complications of chronic haemolysis in paroxysmal nocturnal haemoglobinuria patients on eculizumab
    Hsu, C. H. -W.
    Proven, M.
    Eglinton, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 202 - 203
  • [42] 20 years' experience of eculizumab and ravulizumab therapy in 509 patients with paroxysmal nocturnal haemoglobinuria
    Holt, Matthew
    Kelly, Richard J.
    Vidler, Jennifer
    Arnold, Louise
    Large, Joanna
    Forrest, Briony
    Barnfield, Catherine
    Pike, Alexandra
    Griffin, Morag
    Munir, Talha
    Muus, Petra
    Nagumantry, Sateesh
    Trikha, Roochi
    Kulasekararaj, Austin
    Mitchell, Lindsay
    Gandhi, Shreyans
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 22 - 22
  • [43] Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry
    Almeida, Antonio M.
    Bedrosian, Camille
    Cole, Alexander
    Muus, Petra
    Schrezenmeier, Hubert
    Szer, Jeff
    Rosse, Wendell F.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (09) : 1026 - 1034
  • [44] Megakaryocyte progenitors in paroxysmal nocturnal haemoglobinuria are sensitive to complement
    Basara, N
    Antunovic, P
    Sefer, D
    Radosevic, N
    Gotic, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 57 (03) : 227 - 229
  • [45] Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria: AEGIS Phase II Clinical Study Results
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-Ichi
    Kinoshita, Taroh
    Bedrosian, Camille
    Valentine, Marye Ellen
    Ozawa, Keiya
    Omine, Mitsuhiro
    BLOOD, 2008, 112 (11) : 1179 - 1179
  • [46] Safety and efficacy of the terminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Interim shepherd phase III clinical study.
    Young, Neal S.
    Antonioli, Elisabetta
    Rotoli, Bruno
    Schrezenmeier, Hubert
    Schubert, Joerg
    Urbano-Ispizua, Alvaro
    Coyle, Luke
    de Castro, Carlos
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw P.
    Mojcik, Christopher F.
    Rother, Russell P.
    Hillmen, Peter
    BLOOD, 2006, 108 (11) : 290A - 290A
  • [47] Efficacy of eculizumab against Eosinophilic Fasciitis associated with Paroxysmal Nocturnal Haemoglobinuria
    Frumholtz, L.
    Sebert, M.
    de Masson, A.
    Attias, P.
    Ades, L.
    Roux, J.
    Jachiet, M.
    Cabannes-Hamy, A.
    Noguera, M. Elena
    Attencourt, C.
    Bagot, M.
    Socie, G.
    Rybojad, M.
    de La Tour, R. Peffault
    Bouaziz, J. D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (02) : E101 - E102
  • [48] Successful pregnancy outcome in paroxysmal nocturnal haemoglobinuria on long term eculizumab
    Kelly, R. J.
    Arnold, L. M.
    Richards, S. J.
    Hill, A.
    Bomken, C.
    Hanley, J.
    Loughney, A.
    Beauchamp, J.
    Khursigara, G.
    Rother, R. P.
    Chalmers, E.
    Fyfe, A.
    Fitzsimons, E.
    Nakamura, R.
    Gaya, A.
    Rotoli, B.
    Risitano, A.
    Schubert, J.
    Hillmen, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 23 - 23
  • [49] Treatment with the terminal complement inhibitor eculizumab improves anemia in patients with paroxysmal nocturnal hemoglobinuria:: Phase III triumph study results.
    Schubert, Joerg
    Hillmen, Peter
    Duehrsen, Ulrich
    Young, Neal S.
    Elebute, Modupe
    Szer, Jeffrey
    Gianfaldoni, Giacomo
    Socie, Gerard
    Browne, Paul
    Mojcik, Christopher F.
    Rother, Russell P.
    Muus, Petra
    BLOOD, 2006, 108 (11) : 41A - 41A
  • [50] Pregnancy outcomes in women receiving eculizumab for the management of paroxysmal nocturnal haemoglobinuria
    Anderson, Rachel
    Manning, James
    Hill, Anita
    Ciantar, Etienne
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 132 : 33 - 33
12345